Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001220413 | SCV001392401 | uncertain significance | GM3 synthase deficiency | 2024-11-11 | criteria provided, single submitter | clinical testing | This variant, c.287_289del, results in the deletion of 1 amino acid(s) of the ST3GAL5 protein (p.Lys96del), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (rs779767507, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with ST3GAL5-related conditions. ClinVar contains an entry for this variant (Variation ID: 949035). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV002562505 | SCV003615575 | uncertain significance | Inborn genetic diseases | 2022-05-11 | criteria provided, single submitter | clinical testing | The c.287_289delAAA (p.K96del) alteration is located in exon 3 (coding exon 3) of the ST3GAL5 gene. This alteration consists of an in-frame deletion of 3 nucleotides between nucleotide positions c.287 and c.289, resulting in the deletion of <NA> residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |